{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:28:45Z","timestamp":1788877725709,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001850","name":"Department of Chemicals and Petrochemicals, Ministry of Chemicals and Fertilizers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.colsurfb.2019.110488","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T13:19:11Z","timestamp":1567516751000},"page":"110488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Dendrimer grafted albumin nanoparticles for the treatment of post cerebral stroke damages: A proof of concept study"],"prefix":"10.1016","volume":"184","author":[{"given":"Deepak","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishakha","family":"Tambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Raval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Gondalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2867-1650","authenticated-orcid":false,"given":"Pallab","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3024-3148","authenticated-orcid":false,"given":"Rakesh K.","family":"Tekade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2019.110488_bib0005","first-page":"1","article-title":"Cerebral ischemic stroke: sequels of cascade","volume":"1","author":"Aggarwal","year":"2010","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0010","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s11095-012-0959-2","article-title":"Drug delivery systems for the treatment of ischemic stroke","volume":"30","author":"Rhim","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","article-title":"Executive summary: heart disease and stroke Statistics\u20142016 update","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0020","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/092986708783497337","article-title":"Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging","volume":"15","author":"Slemmer","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0025","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.107.120188","article-title":"Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action","volume":"321","author":"Kim","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/14728222.12.2.159","article-title":"Tissue-type plasminogen activator as a therapeutic target in stroke","volume":"12","author":"Gravanis","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood\u2013brain barrier to blood\u2013brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0040","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2174\/1381612822666161025155058","article-title":"Brain drug delivery systems for the stroke intervention and recovery","volume":"23","author":"Luo","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.colsurfb.2017.04.020","article-title":"Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells","volume":"155","author":"Sharma","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2014.03.013","article-title":"A clinical update of using albumin as a drug vehicle\u2014a commentary","volume":"190","author":"Kratz","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40089-015-0169-0","article-title":"Albumin microparticles as the carriers for allopurinol and applicable for the treatment of ischemic stroke","volume":"6","author":"Aganyants","year":"2016","journal-title":"Int. Nano Lett."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0060","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijpharm.2007.01.031","article-title":"Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio-and testicular toxicity","volume":"337","author":"Pereverzeva","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0065","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1208\/s12249-010-9487-8","article-title":"Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology","volume":"11","author":"Kouchakzadeh","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phrs.2010.10.012","article-title":"Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres","volume":"63","author":"Shen","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2010.12.023","article-title":"Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells","volume":"406","author":"Ulbrich","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0080","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1016\/j.biomaterials.2009.05.060","article-title":"Pharmacokinetics and bone formation by BMP-2 entrapped in polyethylenimine-coated albumin nanoparticles","volume":"30","author":"Zhang","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0085","doi-asserted-by":"crossref","first-page":"15214","DOI":"10.1016\/S0021-9258(18)48160-4","article-title":"Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport","volume":"262","author":"Kumagai","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0090","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/cbdd.12586","article-title":"Cationic albumin\u2010conjugated chelating agent as a novel brain drug delivery system in neurodegeneration","volume":"86","author":"Kamalinia","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.colsurfb.2015.08.008","article-title":"Comparison of different cationized proteins as biomaterials for nanoparticle-based ocular gene delivery","volume":"135","author":"Zorzi","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biomaterials.2016.05.044","article-title":"Nanoscale effects in dendrimer-mediated targeting of neuroinflammation","volume":"101","author":"Nance","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0105","article-title":"Dendrimers as powerful building blocks in central nervous system disease: headed for successful nanomedicine","author":"Leiro","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0110","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/0271678X16630991","article-title":"In vitro models of the blood\u2013brain barrier: an overview of commonly used brain endothelial cell culture models and guidelines for their use","volume":"36","author":"Helms","year":"2016","journal-title":"J. Cerebral Blood Flow Metab."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113126","article-title":"EGb761 provides a protective effect against A\u03b21-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd. 3 endothelial model","volume":"9","author":"Wan","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2018.11.035","article-title":"\u2018Dendrimer-Cationized-Albumin\u2019encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin","volume":"555","author":"Muniswamy","year":"2019","journal-title":"Int. J. Pharma."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ijbiomac.2016.05.032","article-title":"A simple improved desolvation method for the rapid preparation of albumin nanoparticles","volume":"91","author":"Jahanban-Esfahlan","year":"2016","journal-title":"Int. J. Biol. Macromolecules"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/NSA.S117018","article-title":"Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid","volume":"10","author":"Bronze-Uhle","year":"2017","journal-title":"Nanotechnol. Sci. Appl."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jcis.2019.02.073","article-title":"Nanogold-core multifunctional dendrimer for pulsatile chemo-, photothermal-and photodynamic-therapy of rheumatoid arthritis","volume":"544","author":"Pandey","year":"2019","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/21691401.2016.1170694","article-title":"Comparison of protein-and polysaccharide-based nanoparticles for cancer therapy: synthesis, characterization, drug release, and interaction with a breast cancer cell line","volume":"45","author":"Akbal","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0145","first-page":"1","article-title":"Inducing controlled release and increased tumor-targeted delivery of chlorambucil via albumin\/liposome hybrid nanoparticles","author":"Zhang","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/02652048.2018.1425750","article-title":"Microemulsion-based delivery of triamcinolone acetonide to posterior segment of eye using chitosan and butter oil as permeation enhancer: an in vitro and in vivo investigation","volume":"35","author":"Raval","year":"2018","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0155","first-page":"303","article-title":"Antioxidant potential of Fagonia arabica against the chemical ischemia-induced in PC12 cells","volume":"11","author":"Satpute","year":"2012","journal-title":"Iran. J. Pharma. Res.: IJPR"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0160","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1089\/scd.2011.0604","article-title":"Hypoxia-inducible factor 1-\u03b1-AA-modified bone marrow stem cells protect PC12 cells from hypoxia-induced apoptosis, partially through VEGF\/PI3K\/Akt\/FoxO1 pathway","volume":"21","author":"Zhong","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2016.01.046","article-title":"Doxorubicin-loaded nanoparticles consisted of cationic-and mannose-modified-albumins for dual-targeting in brain tumors","volume":"225","author":"Byeon","year":"2016","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0170","doi-asserted-by":"crossref","first-page":"23179","DOI":"10.1038\/srep23179","article-title":"Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer","volume":"6","author":"Kulhari","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0175","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.2147\/IJN.S184379","article-title":"Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration","volume":"13","author":"Huang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1155\/2010\/641545","article-title":"Synthesis and characterization of bovine serum albumin-conjugated copper sulfide nanocomposites","volume":"2010","author":"Huang","year":"2010","journal-title":"J. Nanomater."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuroimage.2016.07.025","article-title":"pH-sensitive MRI demarcates graded tissue acidification during acute stroke\u2015pH specificity enhancement with magnetization transfer and relaxation-normalized amide proton transfer (APT) MRI","volume":"141","author":"Guo","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0190","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s11095-014-1506-0","article-title":"Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics","volume":"32","author":"Tekade","year":"2015","journal-title":"Pharma. Res."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0195","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/02652040802312572","article-title":"Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics","volume":"26","author":"Tekade","year":"2009","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40263-014-0144-8","article-title":"Neuroprotective properties of citicoline: facts, doubts and unresolved issues","volume":"28","author":"Grieb","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1248\/jhs.55.169","article-title":"The effect of generation 2 and 3 poly (amidoamine) dendrimers on viability of human breast cancer cells","volume":"55","author":"Winnicka","year":"2009","journal-title":"J. Health Sci."},{"key":"10.1016\/j.colsurfb.2019.110488_bib0210","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jconrel.2005.03.027","article-title":"Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery","volume":"107","author":"Lu","year":"2005","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2017.03.043","article-title":"Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis","volume":"94","author":"Andreone","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0220","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-2002-36424","article-title":"In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor","volume":"110","author":"Middeke","year":"2002","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.colsurfb.2019.110488_bib0225","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776519306320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776519306320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:41:15Z","timestamp":1760524875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776519306320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":45,"alternative-id":["S0927776519306320"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2019.110488","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendrimer grafted albumin nanoparticles for the treatment of post cerebral stroke damages: A proof of concept study","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2019.110488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110488"}}